RhumbLine Advisers’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11.4M | Sell |
21,764
-1,927
| -8% | -$921K | 0.01% | 997 |
|
|
2025
Q4 | $13.8M | Sell |
23,691
-3,572
| -13% | -$1.82M | 0.01% | 915 |
|
|
2025
Q3 | $12.5M | Buy |
27,263
+900
| +3% | +$336K | 0.01% | 977 |
|
|
2025
Q2 | $7.98M | Sell |
26,363
-1
| -0% | -$298 | 0.01% | 1165 |
|
|
2025
Q1 | $8.73M | Buy |
26,364
+1,924
| +8% | +$632K | 0.01% | 1083 |
|
|
2024
Q4 | $7.54M | Buy |
24,440
+243
| +1% | +$68.3K | 0.01% | 1206 |
|
|
2024
Q3 | $5.14M | Sell |
24,197
-1,154
| -5% | -$295K | ﹤0.01% | 1414 |
|
|
2024
Q2 | $7.1M | Buy |
25,351
+4,209
| +20% | +$1M | 0.01% | 1197 |
|
|
2024
Q1 | $5.65M | Buy |
21,142
+518
| +3% | +$122K | 0.01% | 1349 |
|
|
2023
Q4 | $4.77M | Buy |
20,624
+1,401
| +7% | +$245K | 0.01% | 1445 |
|
|
2023
Q3 | $2.81M | Buy |
19,223
+375
| +2% | +$70.6K | ﹤0.01% | 1680 |
|
|
2023
Q2 | $4.35M | Buy |
18,848
+1,341
| +8% | +$363K | ﹤0.01% | 1455 |
|
|
2023
Q1 | $4.24M | Buy |
17,507
+188
| +1% | +$51.2K | 0.01% | 1418 |
|
|
2022
Q4 | $5.03M | Buy |
17,319
+940
| +6% | +$91.9K | 0.01% | 1273 |
|
|
2022
Q3 | $1.06M | Buy |
16,379
+983
| +6% | +$68.3K | ﹤0.01% | 2107 |
|
|
2022
Q2 | $1.1M | Buy |
15,396
+3,003
| +24% | +$221K | ﹤0.01% | 2091 |
|
|
2022
Q1 | $1.22M | Buy |
12,393
+451
| +4% | +$38K | ﹤0.01% | 2052 |
|
|
2021
Q4 | $1.01M | Sell |
11,942
-171
| -1% | -$14K | ﹤0.01% | 2202 |
|
|
2021
Q3 | $966K | Buy |
12,113
+234
| +2% | +$20.2K | ﹤0.01% | 2232 |
|
|
2021
Q2 | $1.16M | Buy |
11,879
+1,454
| +14% | +$172K | ﹤0.01% | 2180 |
|
|
2021
Q1 | $1.22M | Sell |
10,425
-911
| -8% | -$106K | ﹤0.01% | 2122 |
|
|
2020
Q4 | $1.26M | Buy |
11,336
+174
| +2% | +$21.3K | ﹤0.01% | 2039 |
|
|
2020
Q3 | $1.32M | Sell |
11,162
-2,368
| -18% | -$257K | ﹤0.01% | 1882 |
|
|
2020
Q2 | $1.53M | Buy |
13,530
+2,036
| +18% | +$200K | ﹤0.01% | 1869 |
|
|
2020
Q1 | $767K | Buy |
11,494
+715
| +7% | +$59.6K | ﹤0.01% | 1997 |
|
|
2019
Q4 | $982K | Buy |
10,779
+603
| +6% | +$58.5K | ﹤0.01% | 2095 |
|
|
2019
Q3 | $877K | Buy |
10,176
+36
| +0.4% | +$3.38K | ﹤0.01% | 2100 |
|
|
2019
Q2 | $1.06M | Buy |
10,140
+1,030
| +11% | +$110K | ﹤0.01% | 2042 |
|
|
2019
Q1 | $1.14M | Sell |
9,110
-169
| -2% | -$21K | ﹤0.01% | 1975 |
|
|
2018
Q4 | $1.05M | Buy |
9,279
+3,156
| +52% | +$488K | ﹤0.01% | 1983 |
|
|
2018
Q3 | $1.31M | Buy |
6,123
+429
| +8% | +$108K | ﹤0.01% | 1870 |
|
|
2018
Q2 | $1.59M | Buy |
5,694
+1,551
| +37% | +$272K | ﹤0.01% | 1794 |
|
|
2018
Q1 | $484K | Buy |
4,143
+801
| +24% | +$98.9K | ﹤0.01% | 2223 |
|
|
2017
Q4 | $307K | Buy |
+3,342
| New | +$191K | ﹤0.01% | 2461 |
|
|
2016
Q2 | – | Sell |
-2,566
| Closed | -$22K | – | 3008 |
|
|
2016
Q1 | $22K | Hold |
2,566
| – | – | ﹤0.01% | 2982 |
|
|
2015
Q4 | $32K | Buy |
2,566
+248
| +11% | +$6.81K | ﹤0.01% | 3014 |
|
|
2015
Q3 | $141K | Buy |
2,318
+77
| +3% | +$5.56K | ﹤0.01% | 2886 |
|
|
2015
Q2 | $175K | Buy |
2,241
+389
| +21% | +$32.6K | ﹤0.01% | 2929 |
|
|
2015
Q1 | $126K | Buy |
1,852
+348
| +23% | +$29.8K | ﹤0.01% | 2923 |
|
|
2014
Q4 | $139K | Buy |
1,504
+54
| +4% | +$5.58K | ﹤0.01% | 2903 |
|
|
2014
Q3 | $153K | Buy |
1,450
+8
| +0.6% | +$1.11K | ﹤0.01% | 2850 |
|
|
2014
Q2 | $206K | Buy |
1,442
+316
| +28% | +$46.2K | ﹤0.01% | 2815 |
|
|
2014
Q1 | $170K | Sell |
1,126
-33
| -3% | -$6.5K | ﹤0.01% | 2826 |
|
|
2013
Q4 | $213K | Hold |
1,159
| – | – | ﹤0.01% | 2787 |
|
|
2013
Q3 | $256K | Sell |
1,159
-11
| -0.9% | -$2.34K | ﹤0.01% | 2645 |
|
|
2013
Q2 | $204K | Buy |
+1,170
| New | +$305K | ﹤0.01% | 2974 |
|
Other funds holding MDGL
BBA
RI
ACA
PC
VPM
VCM
